Logo image of MCK

MCKESSON CORP (MCK) Stock Overview

USA - NYSE:MCK - US58155Q1031 - Common Stock

738.06 USD
-20.64 (-2.72%)
Last: 10/3/2025, 7:00:00 PM
738.06 USD
0 (0%)
After Hours: 10/3/2025, 7:00:00 PM

MCK Key Statistics, Chart & Performance

Key Statistics
52 Week High776.14
52 Week Low482.44
Market Cap91.80B
Shares124.38M
Float124.34M
Yearly Dividend2.71
Dividend Yield0.43%
EPS(TTM)33.48
PE22.04
Fwd PE17.36
Earnings (Next)11-04 2025-11-04/amc
IPO11-10 1994-11-10
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Distributors


MCK short term performance overview.The bars show the price performance of MCK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4 6 8

MCK long term performance overview.The bars show the price performance of MCK in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of MCK is 738.06 USD. In the past month the price increased by 7.37%. In the past year, price increased by 52.05%.

MCKESSON CORP / MCK Daily stock chart

MCK Competitors/Peers

The largest stocks on the US markets in the "Health Care Distributors" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
COR CENCORA INC 19.55 58.70B
CAH CARDINAL HEALTH INC 18.75 36.88B
HSIC HENRY SCHEIN INC 14.38 8.13B
AHCO ADAPTHEALTH CORP 29.32 1.23B
AHG AKSO HEALTH GROUP N/A 878.72M
OMI OWENS & MINOR INC 3.26 367.66M
ATPC AGAPE ATP CORP N/A 58.26M
WGRX WELLGISTICS HEALTH INC N/A 57.03M
COSM COSMOS HEALTH INC N/A 32.63M
VRAX VIRAX BIOLABS GROUP LTD N/A 2.68M

About MCK

Company Profile

MCK logo image McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.

Company Info

MCKESSON CORP

6555 State Highway 161

Irving TEXAS 75039 US

CEO: Brian S. Tyler

Employees: 43000

MCK Company Website

MCK Investor Relations

Phone: 19724464800

MCKESSON CORP / MCK FAQ

What is the stock price of MCKESSON CORP today?

The current stock price of MCK is 738.06 USD. The price decreased by -2.72% in the last trading session.


What is the ticker symbol for MCKESSON CORP stock?

The exchange symbol of MCKESSON CORP is MCK and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is MCK stock listed?

MCK stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for MCKESSON CORP stock?

22 analysts have analysed MCK and the average price target is 801.45 USD. This implies a price increase of 8.59% is expected in the next year compared to the current price of 738.06. Check the MCKESSON CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MCKESSON CORP worth?

MCKESSON CORP (MCK) has a market capitalization of 91.80B USD. This makes MCK a Large Cap stock.


How many employees does MCKESSON CORP have?

MCKESSON CORP (MCK) currently has 43000 employees.


What are the support and resistance levels for MCKESSON CORP (MCK) stock?

MCKESSON CORP (MCK) has a support level at 725.46 and a resistance level at 749.22. Check the full technical report for a detailed analysis of MCK support and resistance levels.


Is MCKESSON CORP (MCK) expected to grow?

The Revenue of MCKESSON CORP (MCK) is expected to grow by 12.47% in the next year. Check the estimates tab for more information on the MCK EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy MCKESSON CORP (MCK) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MCKESSON CORP (MCK) stock pay dividends?

MCKESSON CORP (MCK) has a dividend yield of 0.43%. The yearly dividend amount is currently 2.71. Check the full fundamental report for a detailed analysis of MCK dividend history, reliability and sustainability.


When does MCKESSON CORP (MCK) report earnings?

MCKESSON CORP (MCK) will report earnings on 2025-11-04, after the market close.


What is the Price/Earnings (PE) ratio of MCKESSON CORP (MCK)?

The PE ratio for MCKESSON CORP (MCK) is 22.04. This is based on the reported non-GAAP earnings per share of 33.48 and the current share price of 738.06 USD. Check the full fundamental report for a full analysis of the valuation metrics for MCK.


What is the Short Interest ratio of MCKESSON CORP (MCK) stock?

The outstanding short interest for MCKESSON CORP (MCK) is 1.48% of its float. Check the ownership tab for more information on the MCK short interest.


MCK Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to MCK. When comparing the yearly performance of all stocks, MCK is one of the better performing stocks in the market, outperforming 84.61% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MCK Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to MCK. Both the profitability and the financial health of MCK get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MCK Financial Highlights

Over the last trailing twelve months MCK reported a non-GAAP Earnings per Share(EPS) of 33.48. The EPS increased by 19.44% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.84%
ROA 3.89%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%4.82%
Sales Q2Q%23.39%
EPS 1Y (TTM)19.44%
Revenue 1Y (TTM)20.35%

MCK Forecast & Estimates

22 analysts have analysed MCK and the average price target is 801.45 USD. This implies a price increase of 8.59% is expected in the next year compared to the current price of 738.06.

For the next year, analysts expect an EPS growth of 14.76% and a revenue growth 12.47% for MCK


Analysts
Analysts82.73
Price Target801.45 (8.59%)
EPS Next Y14.76%
Revenue Next Year12.47%

MCK Ownership

Ownership
Inst Owners90.18%
Ins Owners0.03%
Short Float %1.48%
Short Ratio2.24